Brought to you by www.DealSearchOnline.com
July 9, 2012 Issue:
Recent Health Care M&A Deals
Spotlight on: Long-Term Care
Spotlight on: Biotechnology
Conference Calendar
Recent Health Care M&A Deals
BIOTECHNOLOGY
Acquirer
Target
Price
Vitrolife
Cryo Management LTD
$6.29 million
LABORATORIES, MRI AND DIALYSIS
Acquirer
Target
Price
Pernix Therapeutics Holdings, Inc.
Great Southern Laboratories
$4.9 million
MANAGED CARE
Acquirer
Target
Price
Detroit Medical Center
ProCare Health Plan, Inc. (HMO)
$6.0 million
MEDICAL DEVICES
Acquirer
Target
Price
Sorin Group
California Medical Laboratories, Inc. (CalMed)
$14.0 million
PHARMACEUTICALS
Acquirer
Target
Price
Bristol-Myers Squibb
Amylin Pharmaeuticals
$7.0 billion
How can we serve you better? Complete our brief survey for a chance to win $250 from AMEX!
What is most important to your business? Is there something you would like to see in one of our publications? We are dedicated to being an integral part of keeping your business ahead of the competition. We would love to hear from you. Fill out our brief publications survey and you will be entered for a chance to win one of two $250 American Express gift cards! http://www.levinassociates.com/pubsurvey
Spotlight on: Long-Term Care
In May’s largest Long-Term Care Deal, Bristal Holdings is selling a portfolio of five seniors living communities in New York State. Bristal is jointly owned by Chartwell Seniors Housing REIT (TSX: CSH-UN) and ING Real Estate Australia Pty. The purchase price is approximately $290.0 million…….Read more
Is Your Company a Power User of Merger and Acquisition Data?
Drive the price of data down to less than 3 cents per item. Call 1-800-248-1668 to learn about our frequency discounts. Go to http://www.dealsearchonline.com, an easy-to-use, award-winning database. This specialized database is an essential 24/7 source for details on health care mergers and acquisitions covering 13 sectors. With approximately 20,000 records of investments and contact names (including e-mail addresses), you’ll get the information you need to make an informed decision any time of the day or night. Call 1-800-248-1668 to learn about our frequency discounts.
Spotlight on: Biotechnology
Abbott Laboratories (NYSE: ABT) is entering into an agreement with Action Pharma A/S to develop and commercialize Action’s AP214, a compound to prevent acute kidney injury associated with major cardiac surgery. Under terms of the deal, ABT will pay Action, a company based in Denmark, $110.0 million upfront……..Read more
Conference Calendar…Click here to see more
